Cargando…
Meta-analysis of Osteopontin splice variants in cancer
BACKGROUND: The cytokine Osteopontin is a mediator of tumor progression and cancer metastasis. In 2006, we reported that (in addition to the full-length form -a) splice variants of Osteopontin (forms -b and -c) are produced selectively by transformed cells. Through June 2021, 36 PubMed-indexed journ...
Autores principales: | An, Yu, Fnu, Gulimirerouzi, Xie, Changchun, Weber, Georg F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124019/ https://www.ncbi.nlm.nih.gov/pubmed/37095438 http://dx.doi.org/10.1186/s12885-023-10854-x |
Ejemplares similares
-
Osteopontin induces mitochondrial biogenesis in deadherent cancer cells
por: Fnu, Gulimirerouzi, et al.
Publicado: (2023) -
Structural Constraint of Osteopontin Facilitates Efficient Binding to CD44
por: Fnu, Gulimirerouzi, et al.
Publicado: (2021) -
RNA blood levels of osteopontin splice variants are cancer markers
por: Hartung, Franz, et al.
Publicado: (2013) -
Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment
por: Fnu, Gulimirerouzi, et al.
Publicado: (2021) -
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
por: Ziółkowski, Piotr, et al.
Publicado: (2022)